Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Il Dong Holdings Co., Ltd. (000230:KRX), powered by AI.
Il Dong Holdings Co., Ltd. is currently trading at ₩7,300. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Il Dong Holdings Co., Ltd. on Alpha Lenz.
Il Dong Holdings Co., Ltd.'s P/E ratio is 7.7.
“Il Dong Holdings Co., Ltd. trades at a P/E of 7.7 (undervalued) with modest ROE of 7.2%.”
Ask for details →Il Dong Holdings Co., Ltd. is a multifaceted corporation primarily engaged in the pharmaceutical and healthcare industry in South Korea. Its core business involves the management and investment in subsidiaries that develop and manufacture pharmaceutical products, including prescription drugs, over-the-counter medications, and health supplements. The company's influence extends to biotechnology, where it invests in research and development to bolster innovations in the medical field. Il Dong Holdings also plays a significant role in the consumer health sector, offering a range of nutraceuticals and wellness products that cater to both local and international markets. As a holding company, it continuously seeks opportunities for growth and diversification within the healthcare domain to maintain a robust presence in the competitive global market. Through strategic management and expansion of its business portfolio, Il Dong Holdings contributes significantly to advancements in health-related solutions, impacting hospitals, pharmacies, and consumers alike. With its headquarters in South Korea, the company integrates its resources and expertise to meet the dynamic demands of the pharmaceutical and healthcare industries effectively.
“Il Dong Holdings Co., Ltd. trades at a P/E of 7.7 (undervalued) with modest ROE of 7.2%.”
Ask for details →Il Dong Holdings Co., Ltd. (ticker: 000230) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 72 employees. Market cap is $84.2B.
The current price is ₩7,300 with a P/E ratio of 7.71x and P/B of 0.5x.
ROE is 7.22% and operating margin is 2.56%. Annual revenue is $590.9B.